November 17, 2025. Karolinska Development AB (Nasdaq Stockholm: KDEV) today announces that its portfolio company Umecrine Cognition has published data in the scientific journal Neuropharmacology, ...
A study has found a previously known cancer-related drug aka nivolumab/relatlimab can be repurposed for Parkinson's disease, ...
Researchers in the University of Georgia's College of Veterinary Medicine have engineered a live bacterium to function as the ...
Symptoms of Parkinson’s disease, which afflicts around 1 million Americans, usually begin gradually and worsen over time.
Parkinson's and Alzheimer's diseases are the two most common neurodegenerative disorders, affecting millions of people ...
Paying attention to patient needs, compassion from the care provider, and tailored therapies can enhance pain care in the ...
A significant number of Parkinson's disease patients experience changes in their sense of smell, such as impaired olfactory ...
Rev. Jesse Jackson was hospitalized in Chicago and has been diagnosed with progressive supranuclear palsy, a ...
Scientists from Duke-NUS Medical School and their collaborators have created one of the most comprehensive single cell maps ...
Researchers have uncovered a shared brain cell breakdown mechanism behind Alzheimer’s and Parkinson’s diseases, revealing how ...
Scientists from Duke-NUS Medical School and their collaborators have created one of the most comprehensive single cell maps ...
What happens in the brain when a person experiences the characteristic movement symptoms of Parkinson's disease? Researchers around the world are seeking answers through various approaches. One of ...